Luethi D - Search Results

1

Molecular and clinical aspects of potential neurotoxicity induced by new psychoactive stimulants and psychedelics.

Rudin D, Liechti ME, Luethi D. Rudin D, et al. Among authors: luethi d. Exp Neurol. 2021 Sep;343:113778. doi: 10.1016/j.expneurol.2021.113778. Epub 2021 Jun 4. Exp Neurol. 2021. PMID: 34090893 Free article. Review.

2

Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs).

Rickli A, Luethi D, Reinisch J, Buchy D, Hoener MC, Liechti ME. Rickli A, et al. Among authors: luethi d. Neuropharmacology. 2015 Dec;99:546-53. doi: 10.1016/j.neuropharm.2015.08.034. Epub 2015 Aug 25. Neuropharmacology. 2015. PMID: 26318099

3

Mechanisms of hepatocellular toxicity associated with new psychoactive synthetic cathinones.

Luethi D, Liechti ME, Krähenbühl S. Luethi D, et al. Toxicology. 2017 Jul 15;387:57-66. doi: 10.1016/j.tox.2017.06.004. Epub 2017 Jun 20. Toxicology. 2017. PMID: 28645576 Free article.

4

Monoamine receptor interaction profiles of 4-thio-substituted phenethylamines (2C-T drugs).

Luethi D, Trachsel D, Hoener MC, Liechti ME. Luethi D, et al. Neuropharmacology. 2018 May 15;134(Pt A):141-148. doi: 10.1016/j.neuropharm.2017.07.012. Epub 2017 Jul 15. Neuropharmacology. 2018. PMID: 28720478

5

Pharmacological profile of mephedrone analogs and related new psychoactive substances.

Luethi D, Kolaczynska KE, Docci L, Krähenbühl S, Hoener MC, Liechti ME. Luethi D, et al. Neuropharmacology. 2018 May 15;134(Pt A):4-12. doi: 10.1016/j.neuropharm.2017.07.026. Epub 2017 Jul 26. Neuropharmacology. 2018. PMID: 28755886 Free article.

6

Pharmacological profile of methylphenidate-based designer drugs.

Luethi D, Kaeser PJ, Brandt SD, Krähenbühl S, Hoener MC, Liechti ME. Luethi D, et al. Neuropharmacology. 2018 May 15;134(Pt A):133-140. doi: 10.1016/j.neuropharm.2017.08.020. Epub 2017 Aug 18. Neuropharmacology. 2018. PMID: 28823611 Free article.

7

Effects of the new psychoactive substances diclofensine, diphenidine, and methoxphenidine on monoaminergic systems.

Luethi D, Hoener MC, Liechti ME. Luethi D, et al. Eur J Pharmacol. 2018 Jan 15;819:242-247. doi: 10.1016/j.ejphar.2017.12.012. Epub 2017 Dec 7. Eur J Pharmacol. 2018. PMID: 29225192

8

Monoamine Transporter and Receptor Interaction Profiles in Vitro Predict Reported Human Doses of Novel Psychoactive Stimulants and Psychedelics.

Luethi D, Liechti ME. Luethi D, et al. Int J Neuropsychopharmacol. 2018 Oct 1;21(10):926-931. doi: 10.1093/ijnp/pyy047. Int J Neuropsychopharmacol. 2018. PMID: 29850881 Free PMC article.

9

The psychostimulant (±)-cis-4,4'-dimethylaminorex (4,4'-DMAR) interacts with human plasmalemmal and vesicular monoamine transporters.

Maier J, Mayer FP, Luethi D, Holy M, Jäntsch K, Reither H, Hirtler L, Hoener MC, Liechti ME, Pifl C, Brandt SD, Sitte HH. Maier J, et al. Among authors: luethi d. Neuropharmacology. 2018 Aug;138:282-291. doi: 10.1016/j.neuropharm.2018.06.018. Epub 2018 Jun 23. Neuropharmacology. 2018. PMID: 29908239 Free article.

10

Stereochemistry of phase-1 metabolites of mephedrone determines their effectiveness as releasers at the serotonin transporter.

Mayer FP, Cintulova D, Pittrich DA, Wimmer L, Luethi D, Holy M, Jaentsch K, Tischberger S, Gmeiner G, Hoener MC, Liechti ME, Mihovilovic MD, Sitte HH. Mayer FP, et al. Among authors: luethi d. Neuropharmacology. 2019 Apr;148:199-209. doi: 10.1016/j.neuropharm.2018.12.032. Epub 2019 Jan 2. Neuropharmacology. 2019. PMID: 30610839

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

44 results

Search Page